Health Professional Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Professional Times.

Press releases published on July 30, 2026

Jul. 30, 2026

Alterity Therapeutics Releases Appendix 4C – Q4 FY26 Quarterly Cash Flow Report & Corporate Update

Indeterminate GlobeNewswire

Jul. 30, 2026

Immunocore to report second quarter 2026 financial results and host call on August 6, 2026

Indeterminate GlobeNewswire

Jul. 30, 2026

INmune Bio Establishes Scientific Advisory Board to Support Late-Stage Development and Expansion of CORDStrom™ Platform

Indeterminate GlobeNewswire

Jul. 30, 2026

Atavistik Bio Partners with Cure HHT Clinical Trial Network to Advance Development of ATV-1601 for Hereditary Hemorrhagic Telangiectasia

Indeterminate GlobeNewswire

Jul. 30, 2026

EyePoint Completes Enrollment of Both Pivotal Phase 3 Trials of DURAVYU™ for Treatment of Diabetic Macular Edema (DME)

Indeterminate GlobeNewswire

Jul. 30, 2026

Madrigal Pharmaceuticals Reports Second-Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

Jul. 30, 2026

Mangoceuticals Announces Business Combination Agreement with Nuclea Energy Inc. to Advance Next-Generation Nuclear Microreactor Technology

Indeterminate GlobeNewswire

Jul. 30, 2026

Beyond Air® Announces Up to $30.1 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules

Indeterminate GlobeNewswire

Jul. 30, 2026

HUTCHMED Reports 2026 Interim Results

Indeterminate GlobeNewswire

Jul. 30, 2026

Phathom Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Jul. 30, 2026

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Completes Patient Enrollment in Phase II Study for Biliary Tract Cancer, Further Demonstrating Breakthrough Potential in Immune-Cold Tumors

Indeterminate GlobeNewswire

Jul. 30, 2026

Donegal Group Inc. Announces Second Quarter and First Half 2026 Results

Indeterminate GlobeNewswire

Jul. 30, 2026

Notice of Knight Therapeutics' Second Quarter 2026 Results Conference Call

Indeterminate GlobeNewswire

Jul. 30, 2026

Avis de conférence téléphonique de Thérapeutique Knight sur ses résultats du deuxième trimestre 2026

Indeterminate GlobeNewswire

Jul. 30, 2026

Norwegian Cruise Line Holdings Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Jul. 30, 2026

Agios Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Jul. 30, 2026

Regeneron Reports Second Quarter 2026 Financial and Operating Results

Indeterminate GlobeNewswire

Jul. 30, 2026

Cytokinetics Announces MHRA Marketing Authorisation for MYQORZO®▼ (aficamten) and Positive Guidance from NICE for Symptomatic Obstructive Hypertrophic Cardiomyopathy in England and Wales

Indeterminate GlobeNewswire

Jul. 30, 2026

Amneal Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Jul. 30, 2026

Questex’s Fierce Pharma announces launch of Fierce Pharma Week Europe in Basel, Switzerland in June 2027

Indeterminate GlobeNewswire